Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Scorpius Holdings Inc (SCPX)

NYSE
Currency in USD
Disclaimer
0.1583
-0.0003(-0.19%)
Closed
After Hours
0.1580-0.0003(-0.1895%)

SCPX Comments

Heat Biologics Inc (NASDAQ: HTBX) reported preclinical data for its gp96-based COVID-19 vaccine candidate showing robust T-cell mediated immune response directed against the spike protein of SARS-CoV-2. The data was generated at the University of Miami Miller School of Medicine. $SRNE $BIOC https://www.heatbio.com/news-media/news-releases/detail/669/heat-biologics-covid-19-vaccine-demonstrates-robust-t-cell
Funding news today?
https://www.streetinsider.com/Corporate+News/Heat+Biologics+%28HTBX%29+Announces+COVID-19+Vaccine+Demonstrates+Robust+T+Cell+Driven+Immune+Response+to+SARS-CoV-2+in+Preclinical+Studies/17237022.html
Who is ready for round 2??????
Has a 471% short increase as reported by shortsqueeze.com. Come in announce some news and ****these shorts and rocket
Shorters will cry for buying this. Wait a while longer-term and you will be glad.
Has a 471% short increase as reported by shortsqueeze.com. Come in announce some news and *****these shorts and rocket
$1.4x then see if it holds
now what ...
i am going to sit tight.
This will be fly and sit in high level cause their work are amazing, I believe in it and hollld strong
*******..
this stock is bipolar. make up your mind already.
this stock is bipolar. make up your mind already.
$HTBX Great news:1- $100 Mn worth of Cash.2- Progress in COVID-19 vaccine program.3- Recognized $0.6 million of grant revenue for qualified expenditures under the CPRIT grant compared to $0.3 million for the quarter ended June 30, 2019.
https://www.google.es/amp/s/finance.yahoo.com/amphtml/news/heat-biologics-provides-second-quarter-110000078.html
PTX-35 is a potential first-in-class T cell co-stimulator targeting TNFRSF25 (Death Receptor 3). Favorable safety profile was demonstrated in mice and non-human primates. PTX-35’s development plan focuses on cancer immunotherapy.Pelican has been awarded a $15.2 million Cancer Prevention Institute of Texas (CPRIT) grant (the “CPRIT Grant”) to support development of PTX-35 and to fund a 70-patient Phase 1 clinical trial.For more information on Pelican and PTX-35,
https://www.heatbio.com/news-media/news-releases/detail/667/heat-biologics-highlights-importance-of-t-cell-immunity-to
All you guys and girls need to relax with HTBX. I know we’re all looking for the next Novavax but this is going to need some kind of news that they reveived a government grant or that they are moving ahead ro ohae 1 clinical trials on their T Cell vaccine! And or they are moving ahead with their lung cancer drug trials. The stock seems to have found a hime between 2.00 and 2.25 and probably will dance in or around this level until we hear what I have stated. True this can mive on any type of positive news but lets be real people a major move will not hapoen unless the government sees potential i. What they are working on or they do a clinical trial tht shows that their T Cell vaccine is working postively in Humans especially thise who are elderly or immuno compromised!
so ?
Daily play with this stock
whats the deep do you see ?
 Deep inside :D hehehe
Good News and he continue drop... its Crazy
It was no a good news.
This looks very interestinghttps://www.fool.com/investing/2020/08/03/2-risky-coronavirus-stocks-that-could-make-you-fil.aspx
it should ******up, I just read the news.
alot of good news, but he continue to drop..why?
This is Stock, no common sense here lol
in at 2.05
in at 1.97:)), if drop, I I sell to find the bottom
https://news.wisc.edu/72318-2/
without the letter C
https://news.wisc.edu/72318-2/c
Here we go!!!! To the Infinity and Beyond!!!!
huh?
Deals with another company to make COVID Vaccine. Read article
how soon can they get government funding?
already they got last Friday so this week going up
link?
more PAIN 💪 looks like otw
...
...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.